SR-9011

DB14014ExperimentalSmall molecule

SR-9011 is a REV-ERB agonist. SR-9011 has been demonstrated that it is specifically lethal to cancer cells and oncogene-induced senescent cells, including melanocytic naevi, and has no effect on the...

Formula / weight: C₂₃H₃₁ClN₄O₃S · 479.04 g/mol (avg)
Code names: SR-9011

Resolves to

Compound

UNIIVYI79FLZ6WCAS1379686-29-9ChEMBLCHEMBL1961797

Structure

InChIKeyPPUYOYQTTWJTIU-UHFFFAOYSA-NSMILESCCCCCNC(=O)N1CCC(CN(CC2=CC=C(S2)[N+]([O-])=O)CC2=CC=C(Cl)C=C2)C1

Targets

Q14995NR1D2P20393NR1D1

What you can answer from here — as of June 12, 2020

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with SR-9011, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account